Vol. 30 (1) 2023 – 01

Vol. 30 (1) 2023

Assessment of diagnostic and prognostic laboratory biomarkers in severe COVID-19 patients admitted to intensive care unit The Egyptian Journal of Immunology Volume 30 (1), January, 2023 Pages: 01–13. www.Ejimmunology.org https://doi.org/10.55133/eji.300101 Mohamed...

Vol. 29 (4) 2022 – 18

Vol. 29 (4) 2022

Antibodies against a mutated citrullinated vimentin in patients with rheumatoid arthritis The Egyptian Journal of Immunology Volume 29 (4), October, 2022 Pages: 184–194. www.Ejimmunology.org https://doi.org/10.55133/eji.290418 Dalia A. Nigm1, Hanan H. Abdel-Lateef1,...

Vol. 29 (4) 2022 – 17

Vol. 29 (4) 2022

Role of IL-17A in enhancing liver fibrosis induced by TGF-β1 and IL-13 in Schistosoma mansoni infected mice The Egyptian Journal of Immunology Volume 29 (4), October, 2022 Pages: 174–183. www.Ejimmunology.org https://doi.org/10.55133/eji.290417 Mohamed H. Abd Allah1,...

Vol. 29 (4) 2022 – 16

Vol. 29 (4) 2022

sVCAM-1, and TGFβ1 in chronic phase, chronic myeloid leukemia patients treated with tyrosine kinase inhibitors The Egyptian Journal of Immunology Volume 29 (4), October, 2022 Pages: 163–173. www.Ejimmunology.org https://doi.org/10.55133/eji.290416 Muhamad R. Abdel...

Vol. 29 (4) 2022 – 15

Vol. 29 (4) 2022

Serum IgG4 level for malignancy prediction in indeterminate thyroid nodules among patients with or without autoimmune thyroid disease The Egyptian Journal of Immunology Volume 29 (4), October, 2022 Pages: 156–162. www.Ejimmunology.org...

Vol. 29 (4) 2022 – 14

Vol. 29 (4) 2022

Serum interleukin-33 (IL-33) in children with active systemic lupus erythematosus: A cross-sectional study The Egyptian Journal of Immunology Volume 29 (4), October, 2022 Pages: 148–155. www.Ejimmunology.org https://doi.org/10.55133/eji.290414 Rana I. Abd-Elazeem1,...